AVGR - Why Is MedTech Firm Avinger Stock Trading Higher Today? | Benzinga
Avinger Inc (NASDAQ: AVGR) shares are trading higher after the company announced the full commercial launch of its Tigereye ST next-generation image-guided chronic total occlusion (CTO) crossing system.
In April 2023, the FDA approved Tigereye ST. Avinger initiated a limited launch.
With the initiation of a full commercial launch, all current and prospective accounts can now order the Full story available on Benzinga.com